MY ACCOUNT | NEWSLETTER |

Sepsis and survival in critically ill calves: risk factors and antimicrobial use


Sepsis is a life-threatening disease for which critically important antimicrobials are frequently used. Diagnostic and therapeutic guidelines for sepsis and critically ill calves are largely lacking.

The aim of the study was to identify factors associated with mortality in critically ill calves and describe bacteria obtained from blood cultures of critically ill calves with sepsis and their antimicrobial resistance.

Logistic regression, survival analysis, and decision tree analysis were used to determine factors associated with mortality.

Researchers enrolled 230 critically ill calves, mainly Belgian Blue beef cattle, in this retrospective cohort study. Of the critically ill calves, 34.3% had sepsis and 61.3% died.

The final survival model indicated that calves with sepsis, abnormal behavior and hypothermia had a significantly higher mortality risk. In a second survival model, hypothermia and hypoglycemia were risk factors for mortality.

Decision tree analysis emphasized the importance of behavior, hypochloremia, hypoglycemia, hyperkalemia, and lung ultrasonography for mortality risk. Escherichia coli (30.6%) was most frequently isolated from blood cultures, of which 90.9% were multidrug resistant. Inappropriate use of antimicrobials was frequent for penicillin, amoxicillin, and sulfamethoxazole/trimethoprim, but less for critically important antimicrobials.

The researchers concluded that many critically ill calves have sepsis, which increases mortality risk. Bacteria involved are often resistant to first-intention antimicrobials but less resistant to critically important antimicrobials.

The other identified risk factors for mortality can support therapeutic decision-making.

Mathilde L Pas, et al. “Sepsis and survival in critically ill calves: Risk factors and antimicrobial use.” J Vet Intern Med. 2022 Dec 23. doi: 10.1111/jvim.16607.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Feline asthma: diagnosis and treatment

Like0
Dislike0

Treatment in canine epilepsy–a systematic review

Like0
Dislike0

Potential applications for antiviral therapy and prophylaxis in bovine medicine

Like0
Dislike0

The future of veterinary care

Like0
Dislike0

Olympic Champion Tara Lipinski Partners with Dutch to Raise Awareness of the Pet Care Gap Affecting 75 Million Americans

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top